Inhibition of Nuclear Factor-Kappa B Activation Decreases Survival of Mycobacterium tuberculosis in Human Macrophages

Xiyuan Bai, Nicole E. Feldman, Kathryn Chmura, Alida R. Ovrutsky, Wen Lin Su, Laura Griffin, Dohun Pyeon, Mischa T. McGibney, Matthew J. Strand, Mari Numata, Seiji Murakami, Loretta Gaido, Jennifer R. Honda, William H. Kinney, Rebecca E Deegan, Dennis R. Voelker, Diane J. Ordway, Edward D. Chan

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Nuclear factor-kappa B (NFκB) is a ubiquitous transcription factor that mediates pro-inflammatory responses required for host control of many microbial pathogens; on the other hand, NFκB has been implicated in the pathogenesis of other inflammatory and infectious diseases. Mice with genetic disruption of the p50 subunit of NFκB are more likely to succumb to Mycobacterium tuberculosis (MTB). However, the role of NFκB in host defense in humans is not fully understood. We sought to examine the role of NFκB activation in the immune response of human macrophages to MTB. Targeted pharmacologic inhibition of NFκB activation using BAY 11-7082 (BAY, an inhibitor of IκBα kinase) or an adenovirus construct with a dominant-negative IκBα significantly decreased the number of viable intracellular mycobacteria recovered from THP-1 macrophages four and eight days after infection. The results with BAY were confirmed in primary human monocyte-derived macrophages and alveolar macrophages. NFκB inhibition was associated with increased macrophage apoptosis and autophagy, which are well-established killing mechanisms of intracellular MTB. Inhibition of the executioner protease caspase-3 or of the autophagic pathway significantly abrogated the effects of BAY. We conclude that NFκB inhibition decreases viability of intracellular MTB in human macrophages via induction of apoptosis and autophagy.

Original languageEnglish (US)
Article numbere61925
JournalPloS one
Volume8
Issue number4
DOIs
StatePublished - Apr 25 2013

Fingerprint

NF-kappa B
Macrophages
Mycobacterium tuberculosis
macrophages
Chemical activation
Survival
autophagy
Autophagy
apoptosis
Mycobacterium
Adenoviridae
caspase-3
Apoptosis
monocytes
infectious diseases
Alveolar Macrophages
phosphotransferases (kinases)
Pathogens
proteinases
pathogenesis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Bai, X., Feldman, N. E., Chmura, K., Ovrutsky, A. R., Su, W. L., Griffin, L., ... Chan, E. D. (2013). Inhibition of Nuclear Factor-Kappa B Activation Decreases Survival of Mycobacterium tuberculosis in Human Macrophages. PloS one, 8(4), [e61925]. https://doi.org/10.1371/journal.pone.0061925

Inhibition of Nuclear Factor-Kappa B Activation Decreases Survival of Mycobacterium tuberculosis in Human Macrophages. / Bai, Xiyuan; Feldman, Nicole E.; Chmura, Kathryn; Ovrutsky, Alida R.; Su, Wen Lin; Griffin, Laura; Pyeon, Dohun; McGibney, Mischa T.; Strand, Matthew J.; Numata, Mari; Murakami, Seiji; Gaido, Loretta; Honda, Jennifer R.; Kinney, William H.; Deegan, Rebecca E; Voelker, Dennis R.; Ordway, Diane J.; Chan, Edward D.

In: PloS one, Vol. 8, No. 4, e61925, 25.04.2013.

Research output: Contribution to journalArticle

Bai, X, Feldman, NE, Chmura, K, Ovrutsky, AR, Su, WL, Griffin, L, Pyeon, D, McGibney, MT, Strand, MJ, Numata, M, Murakami, S, Gaido, L, Honda, JR, Kinney, WH, Deegan, RE, Voelker, DR, Ordway, DJ & Chan, ED 2013, 'Inhibition of Nuclear Factor-Kappa B Activation Decreases Survival of Mycobacterium tuberculosis in Human Macrophages', PloS one, vol. 8, no. 4, e61925. https://doi.org/10.1371/journal.pone.0061925
Bai, Xiyuan ; Feldman, Nicole E. ; Chmura, Kathryn ; Ovrutsky, Alida R. ; Su, Wen Lin ; Griffin, Laura ; Pyeon, Dohun ; McGibney, Mischa T. ; Strand, Matthew J. ; Numata, Mari ; Murakami, Seiji ; Gaido, Loretta ; Honda, Jennifer R. ; Kinney, William H. ; Deegan, Rebecca E ; Voelker, Dennis R. ; Ordway, Diane J. ; Chan, Edward D. / Inhibition of Nuclear Factor-Kappa B Activation Decreases Survival of Mycobacterium tuberculosis in Human Macrophages. In: PloS one. 2013 ; Vol. 8, No. 4.
@article{89a8d35721074243a3fbeb9ed588f958,
title = "Inhibition of Nuclear Factor-Kappa B Activation Decreases Survival of Mycobacterium tuberculosis in Human Macrophages",
abstract = "Nuclear factor-kappa B (NFκB) is a ubiquitous transcription factor that mediates pro-inflammatory responses required for host control of many microbial pathogens; on the other hand, NFκB has been implicated in the pathogenesis of other inflammatory and infectious diseases. Mice with genetic disruption of the p50 subunit of NFκB are more likely to succumb to Mycobacterium tuberculosis (MTB). However, the role of NFκB in host defense in humans is not fully understood. We sought to examine the role of NFκB activation in the immune response of human macrophages to MTB. Targeted pharmacologic inhibition of NFκB activation using BAY 11-7082 (BAY, an inhibitor of IκBα kinase) or an adenovirus construct with a dominant-negative IκBα significantly decreased the number of viable intracellular mycobacteria recovered from THP-1 macrophages four and eight days after infection. The results with BAY were confirmed in primary human monocyte-derived macrophages and alveolar macrophages. NFκB inhibition was associated with increased macrophage apoptosis and autophagy, which are well-established killing mechanisms of intracellular MTB. Inhibition of the executioner protease caspase-3 or of the autophagic pathway significantly abrogated the effects of BAY. We conclude that NFκB inhibition decreases viability of intracellular MTB in human macrophages via induction of apoptosis and autophagy.",
author = "Xiyuan Bai and Feldman, {Nicole E.} and Kathryn Chmura and Ovrutsky, {Alida R.} and Su, {Wen Lin} and Laura Griffin and Dohun Pyeon and McGibney, {Mischa T.} and Strand, {Matthew J.} and Mari Numata and Seiji Murakami and Loretta Gaido and Honda, {Jennifer R.} and Kinney, {William H.} and Deegan, {Rebecca E} and Voelker, {Dennis R.} and Ordway, {Diane J.} and Chan, {Edward D.}",
year = "2013",
month = "4",
day = "25",
doi = "10.1371/journal.pone.0061925",
language = "English (US)",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Inhibition of Nuclear Factor-Kappa B Activation Decreases Survival of Mycobacterium tuberculosis in Human Macrophages

AU - Bai, Xiyuan

AU - Feldman, Nicole E.

AU - Chmura, Kathryn

AU - Ovrutsky, Alida R.

AU - Su, Wen Lin

AU - Griffin, Laura

AU - Pyeon, Dohun

AU - McGibney, Mischa T.

AU - Strand, Matthew J.

AU - Numata, Mari

AU - Murakami, Seiji

AU - Gaido, Loretta

AU - Honda, Jennifer R.

AU - Kinney, William H.

AU - Deegan, Rebecca E

AU - Voelker, Dennis R.

AU - Ordway, Diane J.

AU - Chan, Edward D.

PY - 2013/4/25

Y1 - 2013/4/25

N2 - Nuclear factor-kappa B (NFκB) is a ubiquitous transcription factor that mediates pro-inflammatory responses required for host control of many microbial pathogens; on the other hand, NFκB has been implicated in the pathogenesis of other inflammatory and infectious diseases. Mice with genetic disruption of the p50 subunit of NFκB are more likely to succumb to Mycobacterium tuberculosis (MTB). However, the role of NFκB in host defense in humans is not fully understood. We sought to examine the role of NFκB activation in the immune response of human macrophages to MTB. Targeted pharmacologic inhibition of NFκB activation using BAY 11-7082 (BAY, an inhibitor of IκBα kinase) or an adenovirus construct with a dominant-negative IκBα significantly decreased the number of viable intracellular mycobacteria recovered from THP-1 macrophages four and eight days after infection. The results with BAY were confirmed in primary human monocyte-derived macrophages and alveolar macrophages. NFκB inhibition was associated with increased macrophage apoptosis and autophagy, which are well-established killing mechanisms of intracellular MTB. Inhibition of the executioner protease caspase-3 or of the autophagic pathway significantly abrogated the effects of BAY. We conclude that NFκB inhibition decreases viability of intracellular MTB in human macrophages via induction of apoptosis and autophagy.

AB - Nuclear factor-kappa B (NFκB) is a ubiquitous transcription factor that mediates pro-inflammatory responses required for host control of many microbial pathogens; on the other hand, NFκB has been implicated in the pathogenesis of other inflammatory and infectious diseases. Mice with genetic disruption of the p50 subunit of NFκB are more likely to succumb to Mycobacterium tuberculosis (MTB). However, the role of NFκB in host defense in humans is not fully understood. We sought to examine the role of NFκB activation in the immune response of human macrophages to MTB. Targeted pharmacologic inhibition of NFκB activation using BAY 11-7082 (BAY, an inhibitor of IκBα kinase) or an adenovirus construct with a dominant-negative IκBα significantly decreased the number of viable intracellular mycobacteria recovered from THP-1 macrophages four and eight days after infection. The results with BAY were confirmed in primary human monocyte-derived macrophages and alveolar macrophages. NFκB inhibition was associated with increased macrophage apoptosis and autophagy, which are well-established killing mechanisms of intracellular MTB. Inhibition of the executioner protease caspase-3 or of the autophagic pathway significantly abrogated the effects of BAY. We conclude that NFκB inhibition decreases viability of intracellular MTB in human macrophages via induction of apoptosis and autophagy.

UR - http://www.scopus.com/inward/record.url?scp=84876734256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876734256&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0061925

DO - 10.1371/journal.pone.0061925

M3 - Article

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e61925

ER -